Vimarsana
Biggest News Aggregation in the World

Page 2 - Doris Li News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Doris Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Doris Li Today - Breaking & Trending Today

Online fashion retailer Shein appoints Australian marketing agency - Vimarsana News

Online fashion retailer Shein appoints Australian marketing agency

Online fashion retailer Shein appoints Australian marketing agency July 30, 2021 10:19 Online fashion platform Shein has appointed marketing agency How Communications to its brand account. The Chinese e-commerce company is worth an estimated US$15 billion, with some, such as Insider,  labelling it as a fast fashion brand, that “encourages a cycle of constant buying”. The project is in partnership with Melbourne fashion PR agency Effie & Co, and includes an ongoing 12 month PR campaign to establish the Shein brand in Australia. Ted Wang, country head AUNZ at Shein, said: “The How Commu...

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia - Vimarsana News

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia Regulatory News: Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and MedinCell (Euronext: MEDCL) today announced positive results for study TV46000-CNS-30072 (the RISE study The Risperidone Subcutaneous Extended-Release Study), a Phase 3 clinical trial designed to evaluate the efficacy of TV-46000/mdc-IRM (risperidone extended-release injectable suspension for subcutaneous use) as a treatment for patients with sch...